Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -444.55% | -134.21% | 7.73% | 18.00% | -7.78% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -62.57% | -37.46% | -53.63% | -76.30% | 267.69% |
| Total Other Non-Cash Items | 1,583.87% | 52.74% | -62.17% | -61.03% | -65.48% |
| Change in Net Operating Assets | -17,446.00% | -1,595.92% | 845.86% | -9.39% | -98.29% |
| Cash from Operations | -290.02% | -210.43% | 65.33% | -58.32% | -490.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3,368.47% | -37.69% | -121.75% | 31.00% | -30.11% |
| Total Debt Repaid | -293.02% | -293.02% | 99.91% | 99.91% | -- |
| Issuance of Common Stock | -96.60% | -97.30% | -98.67% | -98.67% | 2,270.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 144.58% | 99.45% | 99.45% | -- |
| Cash from Financing | 630.17% | 305.95% | -105.32% | -87.83% | 507.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,099.06% | 954.53% | -200.98% | -197.78% | 909.69% |